Phase 2 Sleep Disorders Trial, Recruiting (NCT00695214)

Phase 2 Sleep Disorders Trial, Recruiting NCT00695214 Sponsor: University of California, Los Angeles Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT00695214 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults who have been diagnosed with obstructive sleep apnea (OSA) and are considering surgery as a treatment option

Who may not be able to join:

People under 18 years of age
People who are pregnant
People who are not able to give their own consent to participate in English
People who are currently incarcerated (prisoners)
People who have a known allergy to propofol, soybean oil, egg lecithin, or glycerol
People for whom the anesthesiologist or ear, nose, and throat (ENT) doctor has determined that propofol is not a suitable option for other medical reasons (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Eric J Kezirian, MD, MPH, University of California, Los Angeles

Phone: 4242596559

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT00695214

Sponsor: University of California, Los Angeles

Phase: Phase 2

Status: Recruiting

Condition: Sleep Disorders

Trial contact: 4242596559

More information: https://clinicaltrials.gov/study/NCT00695214

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults who have been diagnosed with obstructive sleep apnea (OSA) and are considering surgery as a treatment option

Who may not be able to join:

People under 18 years of age
People who are pregnant
People who are not able to give their own consent to participate in English
People who are currently incarcerated (prisoners)
People who have a known allergy to propofol, soybean oil, egg lecithin, or glycerol
People for whom the anesthesiologist or ear, nose, and throat (ENT) doctor has determined that propofol is not a suitable option for other medical reasons (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

University of California, Los Angeles

Registry

ClinicalTrials.gov

Start date

1 February 2004

Est. completion

1 June 2035

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Association between DISE and physical examination; between DISE and polysomnogram results; between DISE and awake Mueller maneuver; between DISE and lateral cephalometry; and between DISE findings and surgical outcomes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov